Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Zimmer Holdings (NY:ZBH)

103.22 +1.40 (+1.37%)
Official Closing Price Updated: 4:10 PM EDT, Aug 13, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Zimmer Holdings

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Got $1,000? 3 Dividend Stocks to Buy and Hold Forever
Dip into a beaten-down market sector for deals on some proven winners. 
Via The Motley Fool
ZBH Q2 Deep Dive: New Product Launches and M&A Drive Guidance Upgrades
Medical device company Zimmer Biomet (NYSE:ZBH) announced better-than-expected revenue in Q2 CY2025, with sales up 7% year on year to $2.08 billion. Its non-GAAP profit of $2.07 per share was 4.8%... 
Via StockStory
Topics World Trade
A Glimpse Into The Expert Outlook On Zimmer Biomet Holdings Through 5 Analysts
 
Via Benzinga
Stay informed with the top movers within the S&P500 index on Thursday.
Let's delve into the developments on the US markets one hour before the close of the markets on Thursday. Below, you'll find the top gainers and losers within the S&P500 index during today's session. 
Via Chartmill
Earnings Scheduled For August 7, 2025
 
Via Benzinga
What Does the Market Think About Zimmer Biomet Holdings?
 
Via Benzinga
P/E Ratio Insights for Zimmer Biomet Holdings
 
Via Benzinga
Zimmer Biomet (NYSE:ZBH) Exceeds Q2 Expectations, Stock Soars
Medical device company Zimmer Biomet (NYSE:ZBH) beat Wall Street’s revenue expectations in Q2 CY2025, with sales up 7% year on year to $2.08 billion. Its non-GAAP profit of $2.07 per share was 4.8%... 
Via StockStory
Zimmer Biomet's $2.08 Billion Q2 Sales Ignite Orthopedic Surge, Boosts Guidance Outlook
Zimmer Biomet beat Q2 estimates and raised its 2025 earnings forecast, driven by strong hip and knee sales, and new product momentum. 
Via Benzinga
Exploring the top movers within the S&P500 index during today's session.
Let's have a look at what is happening on the US markets in the middle of the day on Thursday. Below you can find the top S&P500 gainers and losers in today's session. 
Via Chartmill
Thursday's session: gap up and gap down stock in the S&P500 index
Thursday's session is showcasing interesting market movements in the S&P500 index, with notable gap up and gap down stocks. Stay updated with the gapping S&P500 stocks in today's session. 
Via Chartmill
Zimmer Biomet (ZBH) Q2 Revenue Jumps 7%
Via The Motley Fool
Topics Economy
Zimmer Biomet (ZBH) Q2 Earnings: What To Expect
Medical device company Zimmer Biomet (NYSE:ZBH) will be reporting earnings this Thursday before the bell. Here’s what you need to know. 
Via StockStory
Topics Artificial Intelligence Government World Trade
Zimmer Biomet Holdings Inc (NYSE:ZBH): A Steady Dividend Performer with Strong Profitability and Financial Stability
Zimmer Biomet (ZBH) offers steady dividends with 10+ years of payouts, strong profitability, and financial health, making it a reliable pick for long-term dividend investors. 
Via Chartmill
Zimmer Biomet Holdings Inc (NYSE:ZBH): A Prime Value Investing Opportunity with Strong Fundamentals and Undervalued Metrics
Zimmer Biomet (ZBH) is a top value stock with strong profitability, low P/E ratios, and solid financial health—ideal for investors seeking undervalued healthcare opportunities. 
Via Chartmill
ZimVie Doubles — And Then Some — On Its Second Takeover Deal
The Zimmer Biomet spinoff is looking to head for private waters under the fund Archimed. 
Via Investor's Business Daily
Get insights into the top movers in the S&P500 index of Tuesday's pre-market session.
Discover the top S&P500 movers in Tuesday's pre-market session and stay informed about market dynamics. 
Via Chartmill
Zimmer Biomet To Lead Orthopedic Robotics With Monogram's AI Tech
Zimmer Biomet plans to acquire Monogram and integrate its robotic knee system into its ROSA platform to support growth and product expansion through 2027. 
Via Benzinga
Topics Artificial Intelligence
Boeing, Uber, Delta Air Lines And A Health Care Stock On CNBC's 'Final Trades'
Stephanie Link, chief investment strategist and portfolio manager at Hightower, picked The Boeing Company as her final trade. 
Via Benzinga
Breaking Down Zimmer Biomet Holdings: 11 Analysts Share Their Views
 
Via Benzinga
Top S&P500 movers in Monday's pre-market session
As the US market prepares to open on Monday, let's get an early glimpse into the pre-market session and identify the S&P500 stocks leading the pack in terms of gains and losses. 
Via Chartmill
3 Healthcare Stocks with Questionable Fundamentals
From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. But speed bumps such as inventory destockings have persisted in the wake of... 
Via StockStory
Topics Artificial Intelligence Stocks
ZIMMER BIOMET HOLDINGS INC (NYSE:ZBH) - A Reliable Dividend Stock Worth Considering
ZIMMER BIOMET HOLDINGS INC (NYSE:ZBH) offers a reliable dividend with strong profitability and reasonable valuation, making it a candidate for income investors. 
Via Chartmill
1 Profitable Stock to Target This Week and 2 to Approach with Caution
While profitability is essential, it doesn’t guarantee long-term success. Some companies that rest on their margins will lose ground as competition intensifies - as Jeff Bezos said, "Your margin is my... 
Via StockStory
Peering Into Zimmer Biomet Holdings's Recent Short Interest
 
Via Benzinga
ZIMMER BIOMET HOLDINGS INC (NYSE:ZBH) - An Undervalued Stock Worth Considering
ZIMMER BIOMET (NYSE:ZBH) is an undervalued medical device stock with strong profitability, a reasonable dividend, and improving growth prospects. A solid pick for value investors. 
Via Chartmill
3 Out-of-Favor Stocks with Questionable Fundamentals
Hitting a new 52-week low can be a pivotal moment for any stock. These floors often mark either the beginning of a turnaround story or confirmation that a company faces serious headwinds. 
Via StockStory
2 Mid-Cap Stocks to Consider Right Now and 1 to Question
Mid-cap stocks have the best odds of scaling into $100 billion corporations thanks to their tested business models and large addressable markets. But the many opportunities in front of them attract... 
Via StockStory
Zimmer Biomet Holdings Inc (NYSE:ZBH) - A Reliable Dividend Stock Worth Considering
Zimmer Biomet Holdings (NYSE:ZBH) offers a reliable dividend with strong profitability and reasonable valuation, making it a solid pick for income investors. 
Via Chartmill
3 S&P 500 Stocks Facing Headwinds
While the S&P 500 (^GSPC) includes industry leaders, not every stock in the index is a winner. Some companies are past their prime, weighed down by poor execution, weak financials, or structural... 
Via StockStory
Topics Stocks
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.